Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of GIAN LIFE CARE. For more details, see the GIAN LIFE CARE quarterly results and GIAN LIFE CARE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.0 |
No. of shares | m | 10.34 |
1 Week | % | -2.7 |
1 Month | % | -12.0 |
1 Year | % | -9.8 |
52 week H/L | Rs | 29.0/18.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
GIAN LIFE CARE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | 22 | 29 | 145 | ||
Low | Rs | NA | 12 | 13 | 12 | ||
Sales per share (Unadj.) | Rs | 558.0 | 16.3 | 22.2 | 15.4 | ||
Earnings per share (Unadj.) | Rs | 100.0 | 2.4 | 4.3 | 4.2 | ||
Diluted earnings per share | Rs | 0.1 | 1.1 | 2.0 | 4.2 | ||
Cash flow per share (Unadj.) | Rs | 121.0 | 2.9 | 4.9 | 4.5 | ||
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | ||
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | ||
Avg Dividend yield | % | 0 | 0 | 0 | 0 | ||
Book value per share (Unadj.) | Rs | 110.0 | 16.3 | 20.5 | 13.6 | ||
Adj. book value per share | Rs | 0.1 | 7.4 | 9.3 | 13.6 | ||
Shares outstanding (eoy) | m | 0.01 | 4.70 | 4.70 | 10.34 | ||
Price / Sales ratio | x | 0 | 1.0 | 0.9 | 5.1 | ||
Avg P/E ratio | x | 0 | 7.1 | 4.9 | 18.6 | ||
P/CF ratio (eoy) | x | 0 | 5.8 | 4.3 | 17.3 | ||
Price / Book Value ratio | x | 0 | 1.0 | 1.0 | 5.8 | ||
Dividend payout | % | 0 | 0 | 0 | 0 | ||
Avg Mkt Cap | Rs m | 0 | 80 | 99 | 813 | ||
Total wages/salary | Rs m | 1 | 10 | 9 | 13 |
GIAN LIFE CARE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 6 | 76 | 105 | 159 | ||
Other income | Rs m | 0 | 1 | 3 | 5 | ||
Total revenues | Rs m | 6 | 77 | 107 | 164 | ||
Gross profit | Rs m | 2 | 23 | 35 | 69 | ||
Depreciation | Rs m | 0 | 3 | 3 | 3 | ||
Interest | Rs m | 0 | 6 | 7 | 13 | ||
Profit before tax | Rs m | 1 | 16 | 28 | 59 | ||
Minority Interest | Rs m | 0 | 0 | 0 | 0 | ||
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | ||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | ||
Tax | Rs m | 0 | 4 | 7 | 15 | ||
Profit after tax | Rs m | 1 | 11 | 20 | 44 | ||
Gross profit margin | % | 35.0 | 30.3 | 33.3 | 43.5 | ||
Effective tax rate | % | 26.0 | 27.7 | 26.8 | 25.3 | ||
Net profit margin | % | 18.0 | 14.7 | 19.3 | 27.4 |
GIAN LIFE CARE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 34 | 41 | 60 | 104 | ||
Current liabilities | Rs m | 67 | 38 | 50 | 69 | ||
Net working cap to sales | % | -593.2 | 3.7 | 9.5 | 22.1 | ||
Current ratio | x | 0.5 | 1.1 | 1.2 | 1.5 | ||
Inventory Days | Days | 977 | 260 | 226 | 207 | ||
Debtors Days | Days | 8,656 | 75,097,860 | 717 | 407 | ||
Net fixed assets | Rs m | 44 | 83 | 95 | 126 | ||
Share capital | Rs m | 0 | 47 | 47 | 103 | ||
"Free" reserves | Rs m | 1 | 29 | 50 | 37 | ||
Net worth | Rs m | 1 | 76 | 97 | 140 | ||
Long term debt | Rs m | 10 | 8 | 6 | 19 | ||
Total assets | Rs m | 78 | 124 | 155 | 231 | ||
Interest coverage | x | 4.1 | 3.6 | 4.8 | 5.7 | ||
Debt to equity ratio | x | 8.9 | 0.1 | 0.1 | 0.1 | ||
Sales to assets ratio | x | 0.1 | 0.6 | 0.7 | 0.7 | ||
Return on assets | % | 1.8 | 14.0 | 17.7 | 24.4 | ||
Return on equity | % | 91.3 | 14.8 | 20.9 | 31.2 | ||
Return on capital | % | 16.5 | 25.8 | 33.9 | 44.7 | ||
Exports to sales | % | 0 | 0 | 0 | 0 | ||
Imports to sales | % | 0 | 0 | 0 | 0 | ||
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | ||
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | ||
Fx inflow | Rs m | 0 | 0 | 0 | 0 | ||
Fx outflow | Rs m | 0 | 0 | 0 | 0 | ||
Net fx | Rs m | 0 | 0 | 0 | 0 |
GIAN LIFE CARE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 30 | 15 | 29 | 58 | ||
From Investments | Rs m | -29 | -40 | -11 | -41 | ||
From Financial Activity | Rs m | 10 | 26 | -4 | 7 | ||
Net Cashflow | Rs m | 10 | 1 | 14 | 23 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Arun Kumar Gupta | COMP SEC: Astha Chaturvedi | YEAR OF INC: 2018 | BSE CODE: 542918 | FV (Rs): 10 | DIV YIELD (%): - |
More Hospital & Healthcare Services Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare GIAN LIFE CARE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.